Regenxbio says gene therapy strengthened boys with Duchenne muscular dystrophy
Based on a small trial with positive muscle performance data, Regenxbio is expected to pursue approval of its gene therapy for Duchenne muscular dystrophy.
Related Articles
GLP-1 Prescribing Decisions: Compounded or Brand-Name?
With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers told us how they cope.
Naurex Inc.’s GLYX-13 Demonstrates Robust, Sustained Antidepressant Effects And Excellent Tolerability In Phase 2b Study
PHOENIX, Dec. 10, 2014 /PRNewswire/ — Naurex Inc. today announced that Phase 2b data presented at the Annual Meeting of the American College of Neuropsychopharmacology…
Cybin Reports Positive Phase 2 Data for CYB003, Demonstrating Breakthrough 12-Month Efficacy in Treating Major Depressive Disorder
– 100% of participants were responsive to treatment and 71% of participants were in remission at 12 months after just two 16 mg doses of…
Academic Institutions Launch Groundbreaking Healthcare AI Challenge
Nov. 13, 2024 — Mass General Brigham AI is hosting the Healthcare AI Challenge, a multi-institutional virtual, interactive series of events where healthcare professionals can…
Market Trends to Watch for Health Systems and Their Specialty Pharmacies – MedCity News
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
Atlas Venture 2024 Year in Review – B. Booth
Atlas Venture partner and LifeSciVC author Bruce Booth shares his 2024 Year in Review. Recorded on November 7, 2024. 00:00 Introduction 01:53 Biopharma Innov…
Leading Indian Hospitals Announce Aggressive Expansion Plans Amidst Heightened Competition in Healthcare – Elets eHealth
Indian healthcare is witnessing an intense expansion phase as prominent hospital chains strategically increase their footprint across the country to meet rising demand and intensify…
Otsuka, ICU Medical form joint venture to boost IV solution supply in North America
Otsuka’s IV solutions subsidiary, Otsuka Pharmaceutical Factory, is breaking into the North American market with the help of a new partner in ICU Medical. |…
Pharmalittle: We’re reading about RFK Jr. and vaccines, obesity-drug prescribing for kids, and more
Robert F. Kennedy Jr. would have broad power as HHS secretary to strip vaccine makers’ protections against lawsuits
Three-Quarters of U.S. Adults Are Now Overweight or Obese
A sweeping new paper reveals the dramatic rise of obesity rates nationwide since 1990.